Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0155
+0.0040
+(34.78%)
As of 12:41:48 PM GMT+1. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard Marsden | CEO, MD & Executive Director | 397.42k | -- | 1967 |
| Prof. Stephen T. Holgate CBE, M.D. | Co-Founder & Member of Scientific Advisory Board | 48.47k | -- | 1947 |
| Mr. Joseph Tregonning Colliver F.C.A. | CFO & Executive Director | 239.19k | -- | 1980 |
| Prof. Donna Davies | Co-Founder & Member of Scientific Advisory Board | -- | -- | -- |
| Prof. Ratko Djukanovic | Co-Founder & Member of Scientific Advisory Board | -- | -- | -- |
| Dr. Gareth E. Walters Ph.D. | Chief Regulatory Officer | -- | -- | 1959 |
| Ms. Jody Brookes | Senior VP & Head of Clinical Operations | -- | -- | -- |
| Mr. Richard Francis | Senior VP and Head of CMC & Quality | -- | -- | -- |
| Dr. Victoria Tear | Head of Laboratory | -- | -- | -- |
| Dr. Marcin Mankowski M.D. | Chief Medical Officer | -- | -- | -- |
Synairgen plc
Mailpoint 810
Level F, South Block Southampton General Hospital Tremona Road
Southampton, SO16 6YD
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 36
Description
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Corporate Governance
Synairgen plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available